Feromin

Quick links to important sections

Feromin

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Feromin

What is Feromin? Overview

Property Description
Active element Ferrous Sulfate or Ferrous Fumarate (Iron)
Form Oral (Tablet, Capsule, or Drops)
Pharmacological class Essential Trace Element Supplement (Iron Preparation)
General purpose Correction of Iron Deficiency
Distinguishing feature Often formulated as well-tolerated oral drops or tablets

What Type of Supplement Is Feromin?

Feromin is classified as an Essential Trace Element Supplement and belongs to the pharmacological class of Iron Preparations. It is designed to provide the body with iron, an essential mineral crucial for health. This targeted supplementation is clinically recognized for supporting fundamental physiological needs, particularly during periods of increased requirement, such as pregnancy. The goal of this medicine is to address and correct the most common elemental deficiency worldwide, making it distinct from broad-spectrum nutritional products.

What Ingredients is Feromin Made From?

The active ingredient in Feromin is typically a specific iron salt, such as Ferrous Sulfate or Ferrous Fumarate. The preparation is usually provided in an oral form, commonly as a tablet, capsule, or a liquid drop formulation. The different forms are designed for specific patient needs; for instance, Feromin is often formulated as an oral drop solution, making it a well-tolerated option for children and individuals who have difficulty swallowing tablets. The specific chemical form, such as a chelate, is engineered for superior absorption compared to simple salts, minimizing gastric irritation.

Why Is Feromin Important for General Health?

Feromin is important because it acts to supply iron, an element essential for the production of hemoglobin, the protein responsible for transporting oxygen throughout the body. By ensuring the body has adequate iron stores, Feromin supports the efficiency of foundational bodily processes, which is crucial for energy metabolism and preventing general fatigue. Maintaining adequate iron levels is a primary factor in sustaining vitality and supporting normal physical resilience across all age groups.

Regulatory References

  1. according to drug information systems on mineral forms
  2. as recognized by the National Institutes of Health

What side effects are possible with Feromin?

Possible Side Effects and Safety Information for Feromin

Feromin is an intravenous iron replacement product associated with a risk of serious, and potentially fatal, hypersensitivity reactions, including anaphylaxis. Due to this risk, the medication must be administered in a setting where emergency equipment and personnel are immediately available to manage a severe reaction.

Patients should not receive this medicine if they have a known allergy to Feromin or any other intravenous iron product, or if they have evidence of iron overload.

Adverse Reaction Category Frequency and Examples
Serious & Clinically Significant Fatal and non-fatal anaphylactic reactions, clinically significant hypotension (low blood pressure), and the risk of iron overload with excessive use. Serious outcomes following hypersensitivity or hypotension may be more severe in elderly patients with existing health issues.
Common Gastrointestinal disorders (e.g., diarrhea, constipation, nausea, vomiting, abdominal pain), Nervous System (e.g., headache, dizziness), and Vascular/General disorders (e.g., hypotension, peripheral edema).
Other Reported Includes other signs of hypersensitivity such as pruritus (itching) and rash.

Close monitoring of the patient is necessary during and for at least 30 minutes following each administration to promptly detect signs of a severe reaction. The medication may also affect the results of certain Magnetic Resonance Imaging (MRI) studies.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of iron preparations, the active element in Feromin, is officially documented to involve stages of acute toxicity. Initial manifestations may include severe gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea. More serious presentations often involve bloody diarrhea or vomiting that resembles coffee grounds, followed by systemic signs like lethargy, a weak and rapid pulse, and low blood pressure (hypotension).

It is explicitly mandated that emergency medical attention must be sought immediately if an overdose is suspected or if the product is accidentally ingested. Urgent medical help is required when clinical signs progress to include symptoms of shock, severe metabolic acidosis, seizures, or coma, as these manifestations indicate life-threatening outcomes such as liver failure.

Regulatory guidance emphasizes that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age. Given this risk, hospitalization is necessary for assessment, even if initial symptoms appear transient. Monitoring procedures documented in official labeling include checking peak serum iron levels and may involve an abdominal X-ray. Specific treatment protocols, including the use of the chelating agent Deferoxamine, are officially described for cases of severe intoxication.

Therapeutic Uses of Feromin

Feromin is commonly used to help manage Iron Deficiency Anemia (IDA) and the underlying state of low blood iron levels, which is its core therapeutic purpose. This therapeutic action is considered relevant for addressing the symptomatic patterns that arise from systemic iron deficits.


Core Management and Symptom Relief

The medication is applied across domains where additional symptomatic support is needed for the treatment of IDA and the relevant management of iron-deficient states. It is used to help address symptoms related to systemic imbalance and is applied in addressing symptoms related to chronic blood loss. Common indications include treating or helping to prevent low iron levels in specific patient groups, such as during pregnancy and periods of high physiological demand.

The treatment may assist with symptomatic relief from constitutional signs of anemia, including debilitating fatigue, profound weakness, and specific manifestations like Restless Legs Syndrome (RLS). This therapeutic action helps to ease these pervasive symptoms, contributing to improved comfort and assisting with the maintenance of functional stability during daily activities.

“Feromin is often applied in situations where symptoms create noticeable functional strain due to chronic elemental deficiency.”


Quick Fact: Relief for Fatigue

Quick Fact: Relief for Fatigue Feromin helps to ease chronic fatigue and weakness when these symptoms are directly linked to iron deficiency, supporting patients during episodes of heightened discomfort and low physical energy.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Feromin (Oral Iron)

Official regulatory documents classify which populations are eligible to use oral iron supplements, defining use as established for adults with confirmed iron deficiency. Use is also generally acceptable in pregnant and lactating women when a clinical indication for the supplement is present.

Contraindicated Populations Age-Related Eligibility Rules
Patients with Hemosiderosis or Hemochromatosis (iron overload syndromes). Adults and Older Adults: Use is established and permitted.
Patients with Hypersensitivity to the active iron salt. Infants and Children: Use of liquid/drop forms is permitted for specific therapeutic purposes.
Patients receiving repeated blood transfusions. Young Children: Solid forms (tablets/capsules) are restricted in very young children (e.g., under 6 years) due to the recognized high risk of accidental fatal iron poisoning.
Patients with anemias not caused by iron deficiency (e.g., Hemolytic Anemia). Pregnancy/Lactation: Use is generally acceptable and often recommended for IDA.
Patients with active Peptic Ulceration or Ulcerative Colitis. Conditional Use: Caution is required in patients with specific active gastrointestinal diseases.

Eligibility is prohibited for any patient with pre-existing conditions that cause iron accumulation. Use is also restricted in patients with specific active gastrointestinal diseases, as stated in the official prescribing information.

What should I know about interactions with other medicines?

Feromin, an iron supplement (often ferrous fumarate or sulfate), can interact with several medications and certain foods or supplements, potentially affecting the absorption and effectiveness of either Feromin or the other product.

Reduced Feromin Absorption

Certain products can reduce the absorption of iron from Feromin, including:

  • Antacids and other stomach acid-reducing medications (e.g., proton pump inhibitors, H2 blockers). These should be taken at least two hours apart from Feromin.
  • Calcium supplements and products containing high amounts of calcium, such as dairy products.
  • Tetracycline and quinolone antibiotics (e.g., ciprofloxacin, doxycycline).
  • Cholestyramine (used for high cholesterol).
  • Coffee and tea should be avoided within one to two hours of taking Feromin.

Reduced Absorption of Other Medicines

Feromin can decrease the absorption of other medications, including:

  • Certain antibiotics (tetracyclines, quinolones).
  • Levothyroxine (used for underactive thyroid).
  • Bisphosphonates (used for osteoporosis, e.g., alendronate).
  • Levodopa, carbidopa, or entacapone (used for Parkinson's disease).

Separating the administration of these medications by two to six hours is often required. Always consult your doctor or pharmacist about a safe dosing schedule for all your current medications and supplements, including over-the-counter products and herbal remedies.

Mechanism of Action

How Feromin Works: Mechanism of Action

Feromin acts through substrate replenishment, delivering elemental iron (in the bioavailable Fe^2+ form) to the gastrointestinal tract, where it is utilized in cellular function and transport processes.

Absorption into the enterocytes occurs primarily via the Divalent Metal Transporter 1 (DMT1). Iron release into circulation is controlled by the hepcidin-ferroportin axis, a feedback regulatory system that governs systemic iron availability and storage as ferritin.

The circulating iron is transported by transferrin predominantly to the bone marrow. Here, it is taken up to act as a critical precursor for the final stages of erythropoiesis. The iron is incorporated into the heme group of the hemoglobin molecule, directly supporting the synthesis of functional oxygen-carrying blood cells. This mechanism of supply supports the synthesis of hemoglobin, resulting in the enhanced oxygen-carrying capacity of the blood and subsequent alteration of tissue oxygenation.

Dosage and Administration Information

How to Use Feromin: Official Administration Guidelines

Feromin (an oral iron preparation) is used according to specific administration guidelines to ensure proper delivery and effective iron repletion. The oral route is the approved method for all available dosage forms, including standard tablets, capsules, and liquid drops.


Official Dosing and Frequency

Category Usage Principle
Standard Dosing Therapeutic use typically falls within a range equivalent to 100 mg to 200 mg elemental iron per day, with lower doses used for prophylaxis.
Frequency Pattern The medication is taken daily, often administered in divided doses (two to three times per day) for therapeutic regimens, though once-daily use is also standard.
Course Duration Use is maintained for an extended period, generally 3 to 6 months after the body's hemoglobin levels have normalized, to ensure complete replenishment of iron stores.

Administration and Handling

To maximize absorption, Feromin is often taken on an empty stomach (e.g., one hour before or two hours after a meal); however, it may be taken with food to improve gastrointestinal tolerance. When administering certain oral forms, specific procedural constraints must be followed: extended-release tablets must be swallowed whole and never crushed or chewed to maintain their intended release profile. Liquid preparations require precise measurement using the provided dropper or dosing device. If a dose is missed, the standard approach is to skip the forgotten dose and resume the regular schedule, without taking a double dose to catch up.

Recent Clinical Evidence

Research evidence / Overview of studies for Feromin

Evidence for Use in Correcting Iron Deficiency Anemia (IDA)

Research for the active ingredient in Feromin has been studied for its use in addressing Iron Deficiency Anemia (IDA). Research examined this use primarily through Randomized Controlled Trials (RCTs) and Systematic Reviews, focusing on adults, children, and pregnant women diagnosed with IDA. Studies monitored key physiological markers, specifically looking at changes in Hemoglobin (Hb) and Serum Ferritin. Studies report how both Hb and Ferritin levels evolved in the observed populations during the study period. These changes were monitored over defined time intervals, generally spanning several months, which is the time observed for key physiological changes to occur. However, the optimal dosing schedule and the full extent of how differences in adherence affect the outcomes for all patients remains a subject of scientific uncertainty.


Evidence for Prevention and Symptom Management

Research was studied for its application in prevention, particularly in conditions where the body's iron requirements may increase, such as during pregnancy. The evidence base includes RCTs and official guideline reviews that monitored outcomes related to the mother, such as the incidence of iron deficiency and anemia diagnosis in the studied population. Findings related to direct, long-term health outcomes for infants are still emerging, and the certainty of evidence for some of these outcomes remains low.

Feromin was also studied for its application in addressing symptoms associated with iron deficiency, such as chronic fatigue and Restless Legs Syndrome (RLS). Research explored fatigue by applying studies examining patient-reported experiences using standardized scales. With RLS, the preparation was evaluated in studies focused on symptom severity in patients with low-to-normal iron stores. Findings were mixed, and evidence for a consistent effect in individuals who are iron-deficient without anemia is limited.


Extended Follow-up and Research Gaps

The majority of pivotal studies were designed to measure short-term or intermediate-term outcomes, and Follow-up durations were limited in many trials. As a result, there is limited information for long-term outcomes regarding the sustained durability of the effect after supplementation is stopped. Data for certain groups, such as older adults with multiple concurrent health conditions, remain insufficient compared to the general studied population. Subgroup findings are uncertain for specific patient groups, emphasizing that results apply only to the populations studied.

Key Studies & References

  1. Iron Supplements Oral - MedlinePlus Drug Information (National Library of Medicine)
  2. WHO recommendation on iron and folic acid supplementation in pregnant women
  3. Oral iron supplements for anaemia in pregnancy (Cochrane Review)
  4. Ferrous Sulfate Oral Tablet Official Label and Monograph (Example Regulatory Document - FDA)

Frequently Asked Questions (FAQ)

Common questions about Feromin (FAQ)

Q: What is the difference between Feromin tablets and Feromin drops?

A: Official administration guidelines state that tablets must be swallowed whole and should not be crushed or chewed. Liquid drops are one of the available formulations and are often used for infants and children who cannot swallow tablets. This form allows for flexible dosing and precise measurement.


Q: Can Feromin be taken at the same time as my multivitamin?

A: Official product information on drug interactions notes that certain ingredients commonly found in multivitamins, such as calcium, can reduce the absorption of iron from Feromin. Regulatory guidelines often recommend separating Feromin from supplements containing calcium by at least two hours to optimize iron absorption.


Q: Is it important to have a blood test before starting Feromin?

A: Feromin is indicated for the correction of confirmed iron deficiency. Regulatory documents state the medicine is contraindicated (should not be used) if anemia is not caused by iron deficiency. Therefore, treatment with Feromin is generally reserved for individuals with a clinical indication of iron deficiency, as determined by a healthcare provider.


Q: How long does it typically take for blood iron levels to return to normal with Feromin?

A: A clinical response, such as a measurable rise in hemoglobin, is often seen in blood tests within 3 to 4 weeks after starting therapy. Full iron storage replenishment, which is measured by serum ferritin levels, often takes an extended period, generally 3 to 6 months, even after the initial hemoglobin improvement is observed.


Q: What are the signs that Feromin is starting to work?

A: Feromin works by supporting the production of hemoglobin, the oxygen-carrying protein in the blood. According to clinical studies, the initial response to treatment is measurable by an increase in hemoglobin concentration in the blood, which may be observed approximately four weeks after starting therapy.


Q: Can Feromin cause constipation or diarrhea?

A: Yes, common side effects of oral iron preparations like Feromin include gastrointestinal disturbances. Official product information lists both diarrhea and constipation, along with nausea, vomiting, and abdominal pain, as common adverse reactions.


Q: What is Feromin used for, besides iron deficiency anemia?

A: Regulatory documents indicate that Feromin is approved for the treatment and prevention of iron deficiency. This includes its use to correct an existing deficiency as well as for prophylaxis (prevention) in populations where the iron requirement is known to increase, such as during pregnancy.


Q: Is the darkening of stool while taking Feromin normal and safe?

A: Yes, regulatory patient information confirms that it is common for Feromin to cause stool to become dark, green, or black. This color change is a common finding caused by unabsorbed iron and is listed in patient information as an expected effect of the medication.


Q: Does taking Feromin on an empty stomach increase its absorption?

A: Yes, to maximize the absorption of iron, official guidelines state that Feromin is often taken on an empty stomach, such as one hour before or two hours after eating a meal. However, the medicine may be administered with food to improve tolerance, though this may slightly reduce iron absorption.


Q: Are there any vitamins or minerals that should be taken at a different time than Feromin?

A: Official interaction summaries note that Feromin absorption can be reduced by taking it simultaneously with certain minerals and supplements. Specifically, calcium supplements and products containing high amounts of calcium should be administered at least two hours apart from Feromin.


Q: Is Feromin the same as other iron supplements like Ferrous Fumarate or Ferrous Gluconate?

A: Feromin is a brand name for an iron preparation that typically contains an iron salt such as Ferrous Sulfate or Ferrous Fumarate. While they share the same purpose of providing elemental iron, Feromin is not chemically identical to every other supplement, which may use different iron salts or have different formulations.


Q: Can Feromin cause a metallic taste in the mouth?

A: Yes, based on patient information provided in regulatory leaflets, an unpleasant or metallic taste in the mouth is one of the reported side effects of oral iron supplementation.


Q: Is Feromin suitable for children?

A: Yes, official guidance states that liquid or drop formulations of Feromin are permitted for specific therapeutic purposes in infants and children. However, regulatory documents include a mandatory warning that solid forms are generally restricted or contraindicated in very young children due to the serious risk of accidental fatal iron poisoning.


Q: Are there any long-term side effects associated with taking Feromin?

A: The main concern with long-term or unnecessary use is the risk of developing iron overload, known as Hemosiderosis or Hemochromatosis. Due to this risk, the medicine is contraindicated for use in patients who already have conditions that cause iron to accumulate.


Q: What happens if I take Feromin for a long time when I don't have an iron deficiency?

A: If Feromin is taken long-term without an iron deficiency, it can lead to excessive iron accumulation in the body, a serious condition known as iron overload. For this reason, official eligibility rules prohibit the use of Feromin for patients with pre-existing iron accumulation conditions.


Q: Does alcohol consumption affect how Feromin works?

A: Specific regulatory documents for oral iron preparations generally indicate that it is safe to consume alcohol while taking the medicine. However, regulatory summaries may note that chronic or excessive alcohol use can potentially influence overall nutritional status and iron absorption.


Q: What are the potential signs of an allergic reaction to Feromin?

A: Signs of an allergic or hypersensitivity reaction, as described in patient information, include rash, hives, or itching. More serious signs of hypersensitivity, which have been reported, include wheezing, tightness in the chest, swelling of the mouth, face, lips, tongue, or throat, or red, swollen, blistering, or peeling skin.


Q: Is there a benefit to taking Feromin with Vitamin C-rich foods or juice?

A: Some patient information documents suggest that the absorption of iron from Feromin may be enhanced by taking the medicine with a source of Vitamin C, such as Vitamin C-rich foods or juice.


Q: Can Feromin cause bloating or gas?

A: While bloating and gas are not specifically listed in all regulatory tables, they are often related to the commonly reported Gastrointestinal disorders. The product label lists symptoms like abdominal pain and general gastrointestinal distress, which often includes related symptoms such as bloating and gas.


Q: Why are people with inflammatory bowel disease cautioned about Feromin?

A: Feromin and other oral iron supplements are contraindicated or must be used with caution in patients with active gastrointestinal diseases, such as active peptic ulceration or ulcerative colitis. This is because iron can potentially irritate the lining of the stomach and intestines.


Q: Can Feromin help with the symptoms of Restless Legs Syndrome?

A: Research indicates that iron preparations like Feromin have been studied for their potential to help with symptoms of Restless Legs Syndrome (RLS) when associated with low iron stores. However, official sources note that findings were mixed, and the evidence for a consistent effect in individuals who are iron-deficient but not anemic remains limited.


Q: What is the typical timeframe for a doctor to check if Feromin is improving iron levels?

A: Clinical guidelines indicate that follow-up blood levels are often assessed to monitor the initial response to treatment. Hemoglobin levels are typically checked within four weeks of starting Feromin therapy, and full iron studies (ferritin) may be repeated at three to four months.

How should Feromin be stored and disposed of?

Storage and Disposal Requirements

Feromin must be stored according to official regulatory requirements to maintain its integrity and potency.

Storage Conditions

The medication is required to be stored at Controlled Room Temperature, typically 20^circC to 25^circC. It must be protected from both moisture and light and should be kept in the original container, tightly closed. Liquid forms of the medicine must not be frozen.


Child-Safety Mandate

All iron-containing products, including Feromin, carry a mandatory warning regarding the risk of fatal poisoning in children. Therefore, the product must be stored out of the sight and reach of children.

Disposal

Expired or unused Feromin must not be disposed of via wastewater or household waste unless explicitly instructed otherwise. Disposal should occur through an official drug take-back program or by mixing with an undesirable substance and placing in a sealed container, following local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Feromin found in:

A-Z Index: